Clinical trials
Recruiting Phase 3 trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
108 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 11 |
| 2023 | 8 |
| 2024 | 20 |
| 2025 | 35 |
| 2026 | 23 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 108 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 13 |
| Pfizer | 10 |
| AstraZeneca | 8 |
| Boehringer Ingelheim | 8 |
| Bayer | 4 |
| Eli Lilly and Company | 3 |
| Gustave Roussy, Cancer Campus, Grand Paris | 3 |
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 3 |
| Tampere University Hospital | 3 |
| Amgen | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 7 |
| Leukemia, Myeloid, Acute | 6 |
| Multiple Myeloma | 6 |
| Endometrial Neoplasms | 5 |
| Prostatic Neoplasms | 5 |
| Heart Failure | 4 |
| Ovarian Neoplasms | 4 |
| Recurrence | 4 |
| COVID-19 | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
Trials
Showing 1 to 25 of 108. Each trial links to its page on Pharma Observatory.
8 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.